MARKET

AMRS

AMRS

Amyris
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.610
-0.150
-3.99%
After Hours: 3.800 +0.19 +5.26% 18:08 10/18 EDT
OPEN
3.770
PREV CLOSE
3.760
HIGH
3.836
LOW
3.580
VOLUME
549.50K
TURNOVER
--
52 WEEK HIGH
8.13
52 WEEK LOW
1.870
MARKET CAP
373.27M
P/E (TTM)
-1.0424
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AMRS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AMRS News

  • WeissLaw LLP: Amyris, Inc. is the Subject of a Legal Investigation
  • PR Newswire.7h ago
  • Amyris Files First-Half 2019 Reports: What Investors Need to Know
  • MotleyFool.com.4d ago
  • 28 Stocks Moving in Friday's Pre-Market Session
  • Benzinga.10/11 12:08
  • Amyris Pipette Brand Successfully Launches on Amazon.com
  • PR Newswire.10/10 13:00

More

Industry

Commodity Chemicals
-0.04%
Chemicals
-0.26%

Hot Stocks

Name
Price
%Change

About AMRS

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. The Company is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including performance chemicals, solvents, lubricants, flavors and fragrances (F&F), cosmetics ingredients, pharmaceuticals, and nutraceuticals. The Company intends to apply its technology to the development of pharmaceutical products. The Company applies its bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.
More

Webull offers Amyris Inc (AMRS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.